Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Hubei Yizhi Konjac Biotechnology Co Pretax Margin % Related Terms
Hubei Yizhi Konjac Biotechnology Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Yizhi Konjac Biotechnology Co Pretax Margin % Chart
BJSE:920273 vs VRTX, REGN, RVMD: Pretax Margin % Comparison
For the Biotechnology subindustry, Hubei Yizhi Konjac Biotechnology Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Yizhi Konjac Biotechnology Co Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hubei Yizhi Konjac Biotechnology Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Hubei Yizhi Konjac Biotechnology Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) has a Pretax Margin % of 7.01% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors. This is 43% below median its historical median of 12.39. Over the past decade, Hubei Yizhi Konjac Biotechnology Co's Pretax Margin % has ranged from 7.75 to 16.94. According to the industry distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #206 out of 944 companies in the Biotechnology industry, placing it in the top 21.8%.
Is Hubei Yizhi Konjac Biotechnology Co's Pretax Margin % too high?
Hubei Yizhi Konjac Biotechnology Co's current Pretax Margin % of 7.01% is 43% below median its 10-year median of 12.39. Over the past 10 years, this metric has ranged from a low of 7.75 to a high of 16.94. Based on the distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #206 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Hubei Yizhi Konjac Biotechnology Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hubei Yizhi Konjac Biotechnology Co's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #206 out of 944 companies for Pretax Margin %. This places Hubei Yizhi Konjac Biotechnology Co in the top 22% of its industry — outperforming the majority of peers. Historically, Hubei Yizhi Konjac Biotechnology Co's own Pretax Margin % has ranged from 7.75 to 16.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors. Hubei Yizhi Konjac Biotechnology Co's current Pretax Margin % is 7.01%, which is 43% below median its own 10-year median of 12.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Yizhi Konjac Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.31, compared to a current price of ¥17.77 — trading 8% below its estimated fair value. The current Pretax Margin % is 7.01%, which is 43% below median its 10-year median of 12.39. Hubei Yizhi Konjac Biotechnology Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Hubei Yizhi Konjac Biotechnology Co (BJSE:920273), the current Pretax Margin % is 7.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co stock appears to be undervalued.
The current stock price of ¥17.77 is trading 8% below its estimated GF Value™ of ¥19.31.
GuruFocus considers Hubei Yizhi Konjac Biotechnology Co to be Fairly Valued.
Key valuation signals for BJSE:920273:
Pretax Margin %: 7.01% (43% below median its 10-year median of 12.39)
GF Value™: ¥19.31 vs. price of ¥17.77 (8% below fair value)
No single metric tells the full story. See the BJSE:920273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Yizhi Konjac Biotechnology Co Ltd is a biotechnology enterprise specializing in the deep processing of konjac. It engages in research and development, production, and sales of konjac-intensive processing and konjac-related products. It has three product categories of konjac gum, konjac food, and konjac tools and nearly 66 product series.
76GF Score
Get the complete analysis for BJSE:920273
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920273 has been successfully added to your 
